Swiss National Bank Heron Therapeutics, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$1.51 - $3.25 $13,288 - $28,600	8,800 Added 3.55%	256,600 $387,000
Q4 2022 Feb 08, 2023	SELL	$2.25 - $4.67 $69,525 - $144,303	-30,900 Reduced 11.09%	247,800 $619,000
Q3 2022 Nov 09, 2022	BUY	$2.66 - $5.37 $101,080 - $204,060	38,000 Added 15.79%	278,700 $1.18 Million
Q2 2022 Aug 09, 2022	BUY	$2.3 - $6.29 $26,909 - $73,593	11,700 Added 5.11%	240,700 $672,000
Q1 2022 May 09, 2022	BUY	$4.63 - $9.94 $70,839 - $152,082	15,300 Added 7.16%	229,000 $1.31 Million
Q3 2021 Nov 08, 2021	BUY	$10.13 - $15.0 $225,899 - $334,500	22,300 Added 11.65%	213,700 $2.28 Million
Q2 2021 Aug 06, 2021	SELL	$13.27 - $18.48 $76,966 - $107,184	-5,800 Reduced 2.94%	191,400 $2.97 Million
Q1 2021 May 07, 2021	BUY	$14.49 - $20.72 $28,980 - $41,440	2,000 Added 1.02%	197,200 $3.2 Million
Q3 2020 Nov 09, 2020	BUY	$13.67 - $17.77 $57,414 - $74,634	4,200 Added 2.2%	195,200 $2.89 Million
Q2 2020 Aug 05, 2020	BUY	$10.89 - $21.47 $273,339 - $538,897	25,100 Added 15.13%	191,000 $2.81 Million
Q1 2020 May 08, 2020	BUY	$10.23 - $24.56 $52,173 - $125,256	5,100 Added 3.17%	165,900 $1.95 Million
Q4 2019 Feb 06, 2020	BUY	$17.42 - $26.61 $341,432 - $521,556	19,600 Added 13.88%	160,800 $3.78 Million
Q3 2019 Nov 12, 2019	BUY	$16.36 - $21.39 $49,080 - $64,170	3,000 Added 2.17%	141,200 $2.61 Million
Q2 2019 Aug 02, 2019	BUY	$16.93 - $26.22 $172,686 - $267,444	10,200 Added 7.97%	138,200 $2.57 Million
Q1 2019 May 10, 2019	BUY	$23.15 - $28.34 $99,545 - $121,862	4,300 Added 3.48%	128,000 $3.13 Million
Q4 2018 Feb 13, 2019	BUY	$22.03 - $32.01 $235,721 - $342,507	10,700 Added 9.47%	123,700 $3.21 Million
Q3 2018 Nov 08, 2018	BUY	$30.0 - $40.85 $381,000 - $518,795	12,700 Added 12.66%	113,000 $3.58 Million
Q1 2018 May 04, 2018	BUY	$18.43 - $28.8 $33,174 - $51,840	1,800 Added 1.83%	100,300 $2.77 Million
Q4 2017 Feb 07, 2018	BUY	$14.8 - $18.85 $296,000 - $377,000	20,000 Added 25.48%	98,500 $1.78 Million
Q3 2017 Nov 03, 2017	BUY	$14.65 - $16.85 $1.15 Million - $1.32 Million	78,500	78,500 $1.27 Million

Others Institutions Holding HRTX

# of Institutions

179

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

Rubric Capital Management LP New York, NY

26.7M
Shares

$41.4 Million
1.48% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.85M
Shares

$13.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

8.72M
Shares

$13.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

8.33M
Shares

$12.9 Million
0.0% of portfolio
Velan Capital Investment Management LP Alpharetta, GA

6.99M
Shares

$10.8 Million
28.8% of portfolio

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $184M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account